Aquestive Therapeutics, Inc. Common Stock AQST
$5.34
-0.19%
at last close
Financials (TTM)
- Revenue
- $54.09 million
- Net Income
- $-78,227,000
- Net Margin
- -144.63%
- Return on Equity
- 138.24%
- Debt-to-Equity
- -0.97
- P/E Ratio
- —
- Price / Book
- -11.84
- Price / Sales
- 12.39
Over the trailing twelve months, Aquestive Therapeutics, Inc. Common Stock generated revenue of $54.09 million and net income of $-78,227,000, a net margin of -144.63%.
At the last closing price of $5.34, AQST trades at 12.39 times sales, with a market capitalization of $670.23 million.
Key Stats
- Last Close
- $5.34
- Market Cap
- $670.23 million
- 52-Week Range
- $2.93 – $7.55
- Average Volume
- 3.30 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.